Failure of propranolol in the treatment of childhood haemangiomas of the head and neck

Journal of Laryngology and Otology

Volumn 125, Issue 11, 2011, Pages 1164-1172

  Goswamy, J ^a   Rothera, M P ^a   Bruce, I A ^a,b  

^a ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Congenital; Face; hemangiomas; Infant; Larynx; Nose; Propranolol

Indexed keywords

PROPRANOLOL;

AIRWAY OBSTRUCTION; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DRUG DOSE INCREASE; FEMALE; HEMANGIOMA; HUMAN; INFANT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; STRIDOR; TREATMENT RESPONSE; TUMOR VOLUME; ULTRASOUND;

ADRENAL CORTEX HORMONES; AIRWAY OBSTRUCTION; ANTI-INFLAMMATORY AGENTS; COMBINED MODALITY THERAPY; COUGH; CUSHING SYNDROME; DIAGNOSIS, DIFFERENTIAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOOT; GLOTTIS; HEAD AND NECK NEOPLASMS; HEMANGIOMA; HUMANS; INFANT; LARYNGOSCOPY; MALE; PROPRANOLOL; RESPIRATORY SOUNDS; SKIN NEOPLASMS; TRACHEOSTOMY; TREATMENT FAILURE;

EID: 80055054811     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215111001538     Document Type: Article

References (22)

1. Mulliken JB, Glowacki J. Mast cell hemangiomas and vascular malformations. Pediatrics 1982;70:48-51
2. Chang LC, Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC et al. Growth characteristics of infantile haemangiomas: implications for management. Pediatrics 2008;122:360-7
3. Leaute-Labreze C, de la Roque ED, Hubiche T, Boralevi F, Thambo JB, Taieb A. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649-51
4. Sanchez Perez R, Cortes Mora P, Gonzalez Rodriguez JD, Rodriguez Sanchez F, De la Pena de Torres J. Treatment of infantile haemangiomas with propranolol [in Spanish]. An Pediatr (Barc) 2008;68:152-4
5. Denoyelle F, Leboulanger N, Enjolras O, Harris R, Roger G, Garabedian EN. Role of propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int J Pediatr Otorhinolaryngol 2009;73:1168-72
6. Jephson CG, Manunza F, Syed S, Mills NA, Harper J, Hartley B E J. Successful treatment of isolated subglottic haemangioma with propranolol alone. Int J Pediatr Otorhinolaryngol 2009;73:1821-3
7. Lawley LP, Siegfried E, Todd JL. Propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol 2009;26:610-14
8. Qin ZP, Liu XJ, Li KL, Zhou Q, Yang XJ, Zheng JW. Treatment of infantile hemangiomas with low-dose propranolol: evaluation of short-term efficacy and safety [in Spanish]. Zhonghua Yi Xue Za Zhi 2009;89:3130-4
9. Maturo S, Hartnick C. Initial experience using propranolol as the sole treatment for infantile airway haemangiomas. Int J Pediatr Otorhinolaryngol 2010;74:323-5
10. Truong MT, Chang KW, Berk DR, Heerema-McKenney A, Bruckner AL. Propranolol for the treatment of a life-threatening subglottic and mediastinal infantile hemangioma. J Pediatr 2010;156:335-8
11. Sans V, Dumas de la Roque E, Berge J, Grenier N, Boralevi F, Mazereeuw-Hautier J et al. Propranolol for severe infantile hemangiomas: follow-up report. Peds 2009;124:e423-31
12. Buckmiller L, Dyamenahalli U, Richter GT. Propranolol for airway hemangiomas: case report of novel treatment. Laryngoscope 2009;119:2051-4
13. Theletsane T, Redfern A, Raynham O, Harris T, Prose NS, Khumalo NP. Life-threatening haemangioma: a dramatic response to propranolol. J Eur Acad Dermatol Venereol 2009;23:1465-6
14. Zimmermann AP, Wiegand S, Werner JA, Eivazi B. Propranolol therapy for infantile haemangiomas: review of the literature. Int J Pediatr Otorhinolaryngol 2010;74:338-42
15. Leon-Villapalos J, Wolfe K, Kangesu L. GLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations. Br J Plast Surg 2005;58:348-52
16. North PE, Waner M, Mizeracki A, Mihm MC. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Human Pathol 2000;31:11-22
17. D'Angelo G, Lee H, Weiner RI. cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation. J Cell Biochem 1997;67:353-66
18. Sommers Smith SK, Smith DM. Beta blockade induces apoptosis in cultured capillary endothelial cells. In Vitro Cell Dev Biol Anim 2002;38:298-304
19. Hoffmann BB. Adrenoreceptor antagonist drugs. In: Katzung BG. Basic and Clinical Pharmacology, 10th edn. New York: McGraw Hill, 2007;147-58
20. Inder T. How long can I go? The impact of hypoglycaemia on the immature brain. Pediatrics 2008;122:440-1
21. Burns CM, Rutherford MA, Boardman JP, Cowan FM. Patterns of cerebral injury and neurodevelopmental outcomes after symptomatic neonatal hypoglycaemia. Pediatrics 2008;122:65-74
22. Bitar MA, Moukarbel RV, Zalzal GH. Management of congenital subglottic haemangioma: trends and success over the past 17 years. Otolaryngol Head Neck Surg 2005;132:226-31